Clinical Trials on Blood Coagulation Disorders
Total 201811 results
-
CSL BehringParexelCompletedVon Willebrand DiseaseUkraine, Lebanon, Germany, Belarus, Georgia, Guatemala
-
CSL BehringParexelCompletedVon Willebrand DiseaseBulgaria, Poland, Russian Federation, Ukraine
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AJapan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AItaly, Sweden, Netherlands, Austria, Spain, United States, Switzerland, Germany, France, Hungary, Greece, Slovenia, Czechia, Slovakia, Poland
-
Novo Nordisk A/SCompletedComparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A SubjectsCongenital Bleeding Disorder | Haemophilia ASpain, Germany, Switzerland, Italy, Israel
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Germany, Switzerland, United Kingdom, Italy, Japan, Turkey
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia ASpain, Germany, Malaysia, Latvia
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited Kingdom, Malaysia
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FVII DeficiencySlovakia, Israel, Spain, India, Iran, Islamic Republic of, Pakistan, Turkey, Germany, Serbia, Italy, Greece, Thailand, France, United States, Hong Kong, Venezuela
-
Nicklaus Children's Hospital f/k/a Miami Children...CompletedAfibrinogenemia | Hypofibrinogenemia | Bleeding DisordersUnited States
-
Ataturk UniversityThe Scientific and Technological Research Council of TurkeyCompletedCoagulation Disorder | Cirrhosis, LiverTurkey
-
CSL BehringCompletedVon Willebrand DiseaseFrance
-
OctapharmaActive, not recruitingVon Willebrand DiseaseUnited States, Moldova, Republic of, Czechia, Germany, North Macedonia, Russian Federation, Ukraine
-
American Thrombosis and Hemostasis NetworkTakedaActive, not recruiting
-
OctapharmaCompletedVon Willebrand DiseasesLebanon, Croatia, United States, Belarus, Bulgaria, Hungary, Russian Federation, Ukraine
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseUnited States, Spain, Australia, Taiwan, Czechia, Turkey, Ukraine, Netherlands, Italy, United Kingdom, Austria, Germany, Russian Federation
-
Nantes University HospitalUniversity Hospital, Angers; Rennes University Hospital; CHU de Brest; CH Le MansCompletedVon Willebrand DiseasesFrance
-
Margaret RagniWyeth is now a wholly owned subsidiary of Pfizer; University of North CarolinaTerminated
-
Laboratoire français de Fractionnement et de BiotechnologiesCompletedVon Willebrand DiseaseNorway, Germany, Italy, Belgium, Czechia, Finland, Greece
-
Skane University HospitalCSL Behring; VersitiCompletedVon Willebrand DiseaseUnited States, Sweden
-
CSL BehringCompletedVon Willebrand DiseaseCanada
-
Spark Therapeutics, Inc.Recruiting
-
Radboud University Medical CenterEnzyre B.V.Not yet recruiting
-
Xue-chun LuRecruiting
-
SanofiRecruitingHemophilia AUnited States
-
Montefiore Medical CenterGenentech, Inc.Not yet recruitingHemophilia AUnited States
-
Emory UniversityTakeda Pharmaceuticals North America, Inc.Recruiting
-
Washington Institute for CoagulationGenentech, Inc.RecruitingHemophilia AUnited States
-
Emory UniversityOctapharmaRecruitingHemophilia AUnited States, Germany
-
Sinocelltech Ltd.Recruiting
-
Medical College of WisconsinRecruitingHemophilia AUnited States
-
TakedaCompleted
-
BayerActive, not recruitingHemophilia ACanada, Spain, United States, Belgium, Italy, Taiwan, Slovenia
-
Hoffmann-La RocheActive, not recruitingHemophilia AChina, Thailand, Hong Kong, Malaysia
-
Bioverativ, a Sanofi companyActive, not recruitingHemophilia AUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom
-
Genzyme, a Sanofi CompanyActive, not recruitingHemophiliaChina, Hungary, Turkey, Canada, Korea, Republic of, United States, Australia, Denmark, France, Germany, India, Ireland, Israel, Italy, Japan, Malaysia, South Africa, Taiwan, Ukraine, United Kingdom
-
HaemnetBioMarin PharmaceuticalCompleted
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.Completed
-
Staidson (Beijing) Biopharmaceuticals Co., LtdCompleted
-
Hospices Civils de LyonCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Swedish Orphan BiovitrumICON plcCompletedHemophilia AFrance, Italy, Norway, Sweden, United Kingdom, Austria, Belgium, Finland, Spain
-
Genzyme, a Sanofi CompanyCompletedHemophiliaUnited States, Australia, China, Denmark, France, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, Turkey, Ukraine, United Kingdom, Mexico
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AUnited States, Belgium, Spain, Japan, Poland, Australia
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AAustralia, Taiwan, Korea, Republic of, France, Germany, Italy, South Africa, Spain, United States, Japan, Ireland, Poland, United Kingdom, Costa Rica
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Grifols Therapeutics LLCInstituto Grifols, S.A.CompletedCongenital AfibrinogenemiaIndia, United States, Italy, Lebanon
-
OctapharmaCompletedHemophilia ANorway, United States, France, United Kingdom, Italy, Czechia, Argentina, Belarus, Ecuador, Guatemala, Lithuania, Portugal, Slovakia
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireTerminatedHemophilia ANetherlands, Spain, Italy, Turkey, Bulgaria, United States, Canada, Germany, Norway, Poland, Russian Federation, South Africa
-
Baxalta now part of ShireCompleted